Intra-aortic counterpulsation for hemodynamic support in patients with acute ischemic versus non-ischemic heart failure

Journal of Invasive Cardiology

Volumn 24, Issue 11, 2012, Pages 583-589

  Lauten, Philipp ^a   Rademacher, Wilma ^a   Goebel, Bjoern ^a   Kretzschmar, Daniel ^a   Figulla, Hans R ^a   Lauten, Alexander ^a   Ferrari, Markus ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

cardiogenic shock; intra aortic counterpulsation; mechanical circulatory support

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COUNTERPULSATION; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEALTH STATUS; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; INTRAAORTIC COUNTERPULSATION; ISCHEMIC HEART FAILURE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATIENT SAFETY; RESUSCITATION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

AGED; COHORT STUDIES; COUNTERPULSATION; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84869475559     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL, Jr. Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113-118.
2. Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbon dioxide) in the aorta\a mechanical assistance to the failing circulation. Am Heart J. 1962;63:669-675.
3. Koenig SC, Litwak KN, Giridharan GA, et al. Acute hemodynamic effcacy of a 32-mL subcutaneous counterpulsation device in a calf model of diminished cardiac function. ASAIO J. 2008;54(6):578-584.
4. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-2945.
5. Antman EM, Anbe D T, Armstrong P W, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(9):E282-E292.
6. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should We Emergently Revascular-ize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341(9):625-634.
7. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol. 2006;2(7):364-377. (Pubitemid 44034187)
8. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34(7):1913-1917. (Pubitemid 43982467)
9. Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling CR. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratifed with the RIFLE criteria. Nephrol Dial Transplant. 2005;20(2):354-360. (Pubitemid 40276892)
10. Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46(6):1038-1048. (Pubitemid 41690229)
11. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classifcation. Ann Thorac Surg. 2006;81(2):542-546. (Pubitemid 43120552)
12. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med. 1973;288(19):979-984.
13. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Catheter Cardiovasc Interv. 2009;74(7):E25-E68.
14. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38(5):1456-1462. (Pubitemid 33033026)
15. Cheng JM, Valk SD, den Uil CA, et al. Usefulness of intra-aortic balloon pump counter-pulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 2009;104(3):327-332.
16. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with car-diogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119(9):1211-1219.
17. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30(17):2102-2108.
18. Koreny M, Karth GD, Geppert A, et al. Prognosis of patients who develop acute renal failure during the frst 24 hours of cardiogenic shock after myocardial infarction. Am J Med. 2002;112(2):115-119. (Pubitemid 34142542)
19. Gol MK, Bayazit M, Emir M, Tasdemir O, Bayazit K. Vascular complications related to percutaneous insertion of intra-aortic balloon pumps. Ann Thorac Surg. 1994;58(5):1476-1480. (Pubitemid 24347546)
20. Barnett MG, Swartz M T, Peterson GJ, et al. Vascular complications from intra-aortic balloons: risk analysis. J Vasc Surg. 1994;19(1):81-87; discussion 87-89.
21. Busch T, Sirbu H, Zenker D, Dalichau H. Vascular complications related to intraaor-tic balloon counterpulsation: an analysis of ten years experience. Thorac Cardiovasc Surg. 1997;45(2):55-59. (Pubitemid 27224013)
22. Manord JD, Garrard CL, Mehra MR, et al. Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg. 1997;26(3):511-515; discussion 515-516.